Fund profile / United Kingdom

Medicxi Fund V

Stage
Seed
Fund size
€500M
Focus
Biotech
Signals
Published
Share
N°01 / About

About Medicxi Fund V

EUR 500M (about $581M) biotech fund combining company creation and investment in existing companies using an asset-centric approach, focused on a single asset per company and typically holding 50%+ ownership in self-funded early-stage companies.

N°02 / Thesis

Investment Focus

Location / RegionUnited Kingdom
Funding StageSeed
Industry Focus
Biotech

Investor Signals Profile

active

Sweet Spot

Clinical/Phase 3 biotech founders targeting $100M+ pharma exits

biotech
asset-centric
company creation
life sciences

Bullish Signals

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Contrarian Signals

Signal text is part of a paid plan
Signal text is part of a paid plan

Founder Do's

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Founder Don'ts

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

29 signals on Medicxi Fund V

12 bullish · 2 contrarian · 10 pitch do's · 3 don'ts · 2 GP profiles, each with its source. From €9/month, cancel anytime.

Michael's Network

Facts

Fund Overview

Fund Size€500M
Saves0
People

Key People

Francesco De RubertisCo-founder and Partner
Giovanni MariggiCo-founder and Partner
N°04 / See also

Related Funds

Foresight Group

Fund size£50M
Location
United Kingdom
Stage
Series A
Focus
Saas
Manager
Matt Smith, Matt Hammond
Series A
Saas
Location
United Kingdom
Stage
Series A
Focus
Deep Tech, Biotech
Manager
Andrew Williamson
Series A
Deep Tech
Biotech
Location
United Kingdom
Stage
Growth
Focus
Creator Economy
Manager
Gary Lineker
Growth
Creator Economy
Connect your agent Free to start. No key, no signup.